In search of developing therapeutic strategies against highly invasive BC in T2DM patients that were associated with high gene expression levels of the ribosomal p70S6K1, we investigated the biological impact of p70S6K1 downregulation and the blockade of its kinase activity on the oncogenic effects of GA on TNBC progression. The gene discussed is RPS6KB1; the disease is type 2 diabetes mellitus.